Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Yunhe Liu¹, Ansam Sinjab², Jimin Min³, Guangchun Han¹, Francesca Paradiso², Yuanyuan Zhang¹, Ruiping Wang¹, Guangsheng Pei¹, Yibo Dai⁴, Yang Liu¹, Kyung Serk Cho¹, Enyu Dai¹, Akshay Basi⁵, Jared K Burks⁵, Kimal I Rajapakshe⁶, Yanshuo Chu¹, Jiahui Jiang¹, Daiwei Zhang⁷, Xinmiao Yan¹, Paola A Guerrero², Alejandra Serrano², Mingyao Li⁷, Tae Hyun Hwang⁸, Andrew Futreal¹, Jaffer A Ajani⁹, Luisa M Solis Soto², Amir A Jazaeri¹⁰, Humam Kadara¹¹, Anirban Maitra¹², Linghua Wang¹³

Affiliations

¹ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁴ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA.
⁵ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁶ Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁷ Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
⁸ Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
⁹ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
¹⁰ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
¹¹ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA. Electronic address: hkadara@mdanderson.org.
¹² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: amaitra@mdanderson.org.
¹³ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: lwang22@mdanderson.org.

PMID: 40154487
PMCID: PMC12074878 (available on 2026-05-12)
DOI: 10.1016/j.ccell.2025.03.004

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Yunhe Liu et al. Cancer Cell. 2025.

. 2025 May 12;43(5):905-924.e6.

doi: 10.1016/j.ccell.2025.03.004. Epub 2025 Mar 27.

Authors

Affiliations

¹ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
³ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁴ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA.
⁵ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁶ Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
⁷ Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
⁸ Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
⁹ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
¹⁰ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
¹¹ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA. Electronic address: hkadara@mdanderson.org.
¹² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: amaitra@mdanderson.org.
¹³ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: lwang22@mdanderson.org.

PMID: 40154487
PMCID: PMC12074878 (available on 2026-05-12)
DOI: 10.1016/j.ccell.2025.03.004

Abstract

Cancer-associated fibroblasts (CAFs) are a multifaceted cell population essential for shaping the tumor microenvironment (TME) and influencing therapy responses. Characterizing the spatial organization and interactions of CAFs within complex tissue environments provides critical insights into tumor biology and immunobiology. In this study, through integrative analyses of over 14 million cells from 10 cancer types across 7 spatial transcriptomics and proteomics platforms, we discover, validate, and characterize four distinct spatial CAF subtypes. These subtypes are conserved across cancer types and independent of spatial omics platforms. Notably, they exhibit distinct spatial organizational patterns, neighboring cell compositions, interaction networks, and transcriptomic profiles. Their abundance and composition vary across tissues, shaping TME characteristics, such as levels, distribution, and state composition of tumor-infiltrating immune cells, tumor immune phenotypes, and patient survival. This study enriches our understanding of CAF spatial heterogeneity in cancer and paves the way for novel approaches to target and modulate CAFs.

Keywords: cancer-associated fibroblast; cell-cell communication; cellular neighborhood; lymphoid aggregate; pan-cancer; spatial multi-omics; spatial transcriptomics; tertiary lymphoid structure; tumor associated macrophage; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.M. receives royalties from Cosmos Wisdom Biotechnology and Thrive Earlier Detection and serves as a consultant for Freenome and Tezcat Biotechnology, and H.K. reports research support from Johnson & Johnson, outside the scope of this work. A.A.J. has served as a consultant for Guidepoint, Gerson Lehrman Group, Nuprobe, AvengeBio, Agenus, AstraZeneca, Iovance, Bristol-Myers Squibb, Eisai, GSK/Tesaro, Macrogenics, Instill Bio, Immune-Onc Therapeutics, Obsidian, Alkermes, and Roche/Genentech, and receives research support from AstraZeneca, Bristol-Myers Squibb, Merck, Eli Lilly, Pfizer, Aravive, and Iovance. A.A.J. is also a shareholder of AvengeBio, outside the scope of this work. L.M.S.S. reports research support from Theolytics and travel support from 10x Genomics, both outside of the scope of this work. T.H.H. is a co-founder of Kure.ai Therapeutics, outside of the scope of this work.

References

1. Caligiuri G, and Tuveson DA (2023). Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell 41, 434–449. 10.1016/j.ccell.2023.02.015. - DOI - PMC - PubMed
1. Chen Y, Zhu S, Liu T, Zhang S, Lu J, Fan W, Lin L, Xiang T, Yang J, Zhao X, et al. (2023). Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell 41, 903–918 e908. 10.1016/j.ccell.2023.03.001. - DOI - PubMed
1. Lavon H, and Scherz-Shouval R (2023). Insights into the co-evolution of epithelial cells and fibroblasts in the esophageal tumor microenvironment. Cancer Cell 41, 826–828. 10.1016/j.ccell.2023.03.020. - DOI - PubMed
1. Tsukui T, Wolters PJ, and Sheppard D (2024). Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature 631, 627–634. 10.1038/s41586-024-07660-1. - DOI - PubMed
1. Sahai E, Astsaturov I, Cukierman E, Denardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al. (2020). A framework for advancing our understanding of cancer-associated fibroblasts. Nature Reviews Cancer 20, 174–186. 10.1038/s41568-019-0238-1. - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Affiliations

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Authors

Affiliations

Abstract

Conflict of interest statement

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical